INS and retinal disorder: Similarly, SGLT2i was associated with a lower risk of sight-threatening retinopathy than sulfonylureas in all subgroups of variables, and the interaction was significant in the insulin subgroup (AHR, 0.76; 95% CI, 0.61-0.94; P = .001) (eTable 4 in Supplement 1).